Acucela - Crunchbase Company Profile & Funding

Q: Where is Acucela's headquarters?

Acucela is located in Seattle, Washington, United States.

Q: When was the last funding round for Acucela?

Acucela closed its last funding round on obfuscated from a Venture - Series Unknown round.

Overview

Acucela

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

See more interactive data and historical milestones on desktop for the best experience

About Acucela

CB Rank

1973465

Acucela is a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the

Founded

obfuscation

Delisted

Venture - Series Unknown

Seattle, Washington, United States

51-100

acucela.com

Biotechnology

Health Care

Pharmaceutical

Therapeutics

Funding Rounds

Venture - Series Unknown

OBF

obfuscation

Key People

Jeffrey Gregory: Chief Medical Director
Past Role: MediQuest Therapeutics, Chief Medical Officer
Kathy Hasegawa: Controller
Past Role: WineBid.com, Controller

Details

Operating Status

Active

Stock Symbol

TYO:4589

Company Type

For Profit

About the Company

Acucela is a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases impacting millions of individuals worldwide.

Phone Number

+1-425-527-3260

Contact Email

pr@acucela.com

Predictions & Insights

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Acucela	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Acucela	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Acucela	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Acucela	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Acucela	—	obfuscated obfuscation	—	Venture - Series Unknown

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Acucela	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Acucela	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Acucela	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Acucela	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Acucela	—	obfuscated obfuscation	—	Venture - Series Unknown

Investors

Market Intelligence

People

View Profiles & Contacts

Headcount

51-100

Employee Profiles

Board Members and Advisors

Contacts

Employee Profiles

Jeffrey Gregory Chief Medical Director
Kathy Hasegawa Controller
Nathan Mata Clinical Research & Operations Consultant
Ryo Kubota Representative Executive Officer, Chairman, President and Chief Executive Officer